Loading…
CIK 0001652044 • 6 13F filings • May 2, 2025 – Aug 7, 2026
Import this data to Google Sheets with:
=jivedata("alphabet-inc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ARM HOLDINGS PLC | SPONSORED ADS | $214.3M | 8.3%Prev: 11.5% | 1,960,784 SH | Decreased |
| AST SPACEMOBILE INC | COM CL A | $649.6M | 25.2%Prev: 18.2% | 8,943,486 SH | Increased |
| AUTOLUS THERAPEUTICS PLC | SPON ADS | $1.4M | 0.1%Prev: 0.0% | 698,262 SH | Increased |
| BEAM THERAPEUTICS INC | COM | $8.9M | 0.3%Prev: 0.3% | 321,604 SH | Increased |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW | $35.3M | 1.4%Prev: 1.4% | 2,823,126 SH | Increased |
| DEXCOM INC | COM | $68.8M | 2.7%Prev: 2.9% | 1,036,937 SH | Decreased |
| EXACT SCIENCES CORP | COM | $2.4M | 0.1%Prev: 0.1% | 23,205 SH | Increased |
| FIGMA INC | CLASS A COM STK | $8.1M | 0.3%Prev: 0.5% | 215,582 SH | Decreased |
| FRESHWORKS INC | CLASS A COM | $198.5M | 7.7%Prev: 7.9% | 16,206,643 SH | Increased |
| FULCRUM THERAPEUTICS INC | COM | $161K | 0.0%Prev: 0.0% | 14,262 SH | Increased |
| GENEDX HOLDINGS CORP | COM | $3.0M | 0.1%Prev: 0.1% | 22,711 SH | Increased |
| GITLAB INC | CLASS A COM | $102.3M | 4.0%Prev: 5.1% | 2,724,712 SH | Decreased |
| HYPERFINE INC | COM CL A | $881K | 0.0%Prev: 0.1% | 898,720 SH | Decreased |
| LYELL IMMUNOPHARMA INC | COM NEW | $9.0M | 0.3%Prev: 0.2% | 293,256 SH | Increased |
| MAZE THERAPEUTICS INC | COM | $57.5M | 2.2%Prev: 2.6% | 1,388,583 SH | Decreased-1,023,888 SH |
| MONTE ROSA THERAPEUTICS INC | COM | $11.7M | 0.5%Prev: 0.5% | 744,948 SH | Increased-719,067 SH |
| OSCAR HEALTH INC | CL A | $6.9M | 0.3%Prev: 0.4% | 481,988 SH | Decreased |
| PLANET LABS PBC | COM CL A | $629.9M | 24.4%Prev: 17.2% | 31,942,641 SH | Increased |
| PRIME MEDICINE INC | COM | $57.5M | 2.2%Prev: 3.8% | 16,562,498 SH | Decreased |
| QUINCE THERAPEUTICS INC | COM | $634K | 0.0%Prev: 0.0% | 189,122 SH | Increased |
| RELAY THERAPEUTICS INC | COM | $13.3M | 0.5%Prev: 0.3% | 1,568,753 SH | Increased |
| REPLIGEN CORP | COM | $63K | 0.0%Prev: 0.0% | 383 SH | Increased |
| REVOLUTION MEDICINES INC | COM | $266.4M | 10.3%Prev: 8.0% | 3,345,102 SH | Increased-788,175 SH |
| SANA BIOTECHNOLOGY INC | COM | $11.4M | 0.4%Prev: 0.4% | 2,812,500 SH | Increased |
| SPERO THERAPEUTICS INC | COM | $2.1M | 0.1%Prev: 0.1% | 889,979 SH | Increased |
| TEMPUS AI INC | CL A | $91.6M | 3.6%Prev: 5.2% | 1,551,102 SH | Decreased |
| TENAYA THERAPEUTICS INC | COM | $650K | 0.0%Prev: 0.1% | 915,705 SH | Decreased |
| UIPATH INC | CL A | $115.3M | 4.5%Prev: 3.9% | 7,034,337 SH | Increased |
| VERA THERAPEUTICS INC | CL A | $12.2M | 0.5%Prev: 0.3% | 241,264 SH | Increased |
| 13F-HR |
| 0001652044-26-000073 |
| $99.08B |
| View |
| Aug 1, 2025 | Q2 2025 | 13F-HR | 0001652044-25-000063 | $2.14B | View |
| May 8, 2026 | Q1 2026 | 13F-HR | 0001652044-26-000051 | $4.02B | View |
| May 2, 2025 | Q1 2025 | 13F-HR | 0001652044-25-000045 | $1.58B | View |